Anteris Technologies Launches $250M At-The-Market Equity Offering
AVR has more than doubled off its 52-week low of $2.85 on elevated volume (2.4× avg).
Summary
Anteris Technologies Global Corp. launched a new At-The-Market (ATM) offering to sell up to $250 million of common stock, providing significant capital for product development but also posing substantial dilution risk.
Key Events · Financing and Capital Events · AVR
-
New At-The-Market (ATM) Offering
Anteris Technologies Global Corp. entered into a sales agreement with TD Securities (USA) LLC to offer and sell up to $250 million of common stock through an At-The-Market program.
-
Significant Potential Dilution
The offering represents a potential capital raise of approximately 26.7% of the company's current market capitalization. If the full amount were sold at an assumed price of $9.00 per share, it would result in an immediate dilution of $4.84 per share for new investors and a potential increase of approximately 28.5% in outstanding shares.
-
Use of Proceeds
Net proceeds are intended primarily for the ongoing development of the DurAVR® THV System, with the remainder allocated to working capital and general corporate purposes.
-
Follows Prior Capital Raise
This new ATM program follows a previously reported $320 million capital raise, further strengthening the company's financial runway amidst prior going concern warnings.
Analysis · AVR · Industrial Applications And Services
Anteris Technologies Global Corp. has established a new At-The-Market (ATM) equity program to sell up to $250 million in common stock. This represents a substantial potential capital raise, equivalent to approximately 26.7% of the company's current market capitalization, and could result in significant dilution for existing shareholders. While dilutive, this capital is crucial for a development-stage medical technology company like Anteris, particularly following previous disclosures of a going concern warning and recent Q1 2026 results that highlighted a prior $320 million capital raise. The proceeds are earmarked for the ongoing development of its DurAVR® THV System and general corporate purposes, extending its financial runway.
At the time of this filing, AVR was trading at $9.16 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $936.4M. The 52-week trading range was $2.85 to $9.79. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.